Brief: Sun Pharma Advanced Research Says Two Serious Adverse Events In SCO-088

Sun Pharma Advanced Research

19/09/2019 12:35

Sept 19 (Reuters) - Sun Pharma Advanced Research Company Ltd
 SPRC.NS :
    * SAYS OBSERVED TWO SERIOUS ADVERSE EVENTS IN STUDY OF
LEUKEMIA
DRUG CANDIDATE SCO-088
    * SAYS END OF PHASE 1 MEETING WITH USFDA FOR SCO-088
COMPLETED

Source text for Eikon:  ID:nBSE12Y57c 
Further company coverage:  SPRC.NS 

 ((bangalore.newsroom@thomsonreuters.com;))